Sort
51,593 grants matching “hepatitis”
PEG-like Multimodal Nanoprobes for Imaging Enhanced Permeability Retention
$389,057Marc David Normandin · Massachusetts General Hospital · R01 · FY2017 · EB
PEG-like Multimodal Nanoprobes for Imaging Enhanced Permeability Retention
$389,057Charalambos Kaittanis · Massachusetts General Hospital · R01 · FY2016 · EB
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
$389,052Aaron Grossberg · Oregon Health & Science University · R37 · FY2023 · CA
HCV NS3 and NS5A: Biochemical Mechanisms and Biological Functions
$389,046Kevin D Raney · Univ Of Arkansas For Med Scis · R56 · FY2009 · AI
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2020 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2022 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2023 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2019 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2021 · AA
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
$389,028Jessica L Maiers · Indiana University Indianapolis · R01 · FY2025 · DK
Clinical Application of Image Guided Liver Surgery
$388,969Washington University · R33 · FY2005 · CA
Modulation of HCV Gene Expression
$388,965Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · R01 · FY2006 · DK
Lipotoxicity in Alcoholic Liver Disease
$388,951Zhanxiang Zhou · University Of North Carolina Greensboro · R01 · FY2015 · AA
Molecular Pharmacology of Insulin Resistance in Burns
$388,933Jeevendra Martyn · Massachusetts General Hospital · R01 · FY2010 · GM
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1
$388,915Margaret O James · University Of Florida · R01 · FY2017 · GM
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$388,908Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Hepatitis B Clinical Research Network
$388,900Arun J Sanyal · Virginia Commonwealth University · U01 · FY2009 · DK
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$388,872Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2025 · DK
Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes
$388,865Melissa A Runge-Morris · Wayne State University · R01 · FY2015 · ES
Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes
$388,865Melissa A Runge-Morris · Wayne State University · R01 · FY2018 · ES
Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes
$388,865Melissa A Runge-Morris · Wayne State University · R01 · FY2016 · ES
Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes
$388,865Melissa A Runge-Morris · Wayne State University · R01 · FY2017 · ES
Phospholipid-Mediated Metabolic Control in the Liver
$388,863David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · DK
The role of the Akt/PKB signaling in insulin action
$388,855Morris J Birnbaum · University Of Pennsylvania · R01 · FY2011 · DK
Viral use and mimicry of autophagy pathway and components
$388,820Karla Kirkegaard · Stanford University · R01 · FY2019 · AI